Literature DB >> 6702772

Polymicrobial bacteremia in pediatric patients.

G T Frommell, J K Todd.   

Abstract

Of 1,352 positive pediatric blood cultures during a 3.6-year period, two or more microorganisms grew from 72 cultures (5.3%), representing 60 patients. Based on predefined operational criteria for clinical interpretation of blood cultures, these cases were retrospectively classified as polymicrobial bacteremia (each organism, ie, a pathogen, 30%), mixed bacteremia/contaminant (20%), or multiple contaminants (50%). Considered individually, gram-positive organisms were isolated more frequently but were more often judged to be contaminants than the less common gram-negative organisms, which were more often thought to be true pathogens. Although one child did have a combined Streptococcus pneumoniae/Hemophilus influenzae bacteremia, these more common pediatric pathogens were underrepresented in those patients with polymicrobial bacteremia, from whom Enterobacteriaceae, streptococci, staphylococci, and anaerobes were more commonly isolated. Hospitalization for a predisposing illness and/or a focus of infection occurred in 88% of the children with confirmed polymicrobial bacteremia.

Entities:  

Mesh:

Year:  1984        PMID: 6702772     DOI: 10.1001/archpedi.1984.02140410044014

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

Review 1.  Detection of bloodstream infections in children.

Authors:  J M Campos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

2.  Polymicrobial bacteremia.

Authors:  Y Siegman-Igra; D Schwartz; N Konforti
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

3.  Pediatric patients with intravascular devices: polymicrobial bloodstream infections and risk factors.

Authors:  Wes Onland; Dasja Pajkrt; Cathy Shin; Stana Fustar; Teresa Rushing; Wing-Yen Wong
Journal:  J Pathog       Date:  2011-04-18

Review 4.  Clinical review: bacteremia caused by anaerobic bacteria in children.

Authors:  Itzhak Brook
Journal:  Crit Care       Date:  2002-05-09       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.